The role of drug-eluting stents for the treatment of coronary chronic total occlusions

References

• Garcia S, Abdullah S, Banerjee S, Brilakis ES. Chronic total occlusions: patient selection and overview of advanced techniques. Curr. Cardiol. Rep. 15, 334 (2013).
   PubMed Web of Science ®Google Scholar
• Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am. Heart. J. 160, 179–187 (2010).
   PubMed Web of Science ®Google Scholar
• Khan MF, Wendel CS, Thai HM, Movahed MR. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter. Cardiovasc. Interv. 82, 95–107 (2013).
   PubMed Web of Science ®Google Scholar
• Muramatsu T, Hiranom K, Tsukahara R et al. Long-term outcome of percutaneous transluminal coronary intervention for chronic total occlusion in the BMS era in Japan. Cardiovasc. Interv. Ther. 25, 78–84 (2010).
   PubMedGoogle Scholar
• Werner GS, Surber R, Kuethe F et al. Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion. Am. Heart J. 149, 129–137 (2005).
   PubMed Web of Science ®Google Scholar
• Nombela-Franco L, Mitroi CD, Fernandez-Lozano I et al. Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Circ. Arrhythm. Electrophysiol. 5, 147–154 (2012).
   PubMed Web of Science ®Google Scholar
• Claessen BE, Dangas GD, Weisz G et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur. Heart J. 33, 768–775 (2012).
   PubMed Web of Science ®Google Scholar
• Agostoni P, Valgimigli M, Biondi-Zoccai GG et al. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era. Am. Heart J. 151, 682–689 (2006).
   PubMed Web of Science ®Google Scholar
• Buller CE, Dzavik V, Carere RG et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 100, 236–242 (1999).
   PubMed Web of Science ®Google Scholar
• Saeed B, Kandzari DE, Agostoni P et al. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Catheter. Cardiovasc. Interv. 77, 315–332 (2011).
   PubMed Web of Science ®Google Scholar
• Werner GS, Gitt AK, Zeymer U et al. Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clin. Res. Cardiol. 98, 435–441 (2009).
   PubMed Web of Science ®Google Scholar
• Claessen BE, van der Schaaf RJ, Verouden NJ et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc. Interv. 2, 1128–1134 (2009).
   PubMed Web of Science ®Google Scholar
• Tarantini G, Facchin M, Capodanno D et al. Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter?: long-term clinical outcome of 2,429-patient multicenter registry. Catheter. Cardiovasc. Interv. 81, 80–89 (2013).
   PubMed Web of Science ®Google Scholar
• Buja P, Facchin M, Musumeci G et al. Paclitaxel- and sirolimus-eluting stents in older patients with diabetes mellitus: results of a real-life multicenter registry. Catheter. Cardiovasc. Interv. 81, 1117–1124 (2013).
   PubMed Web of Science ®Google Scholar
• Brilakis ES, Saeed B, Banerjee S. Drug-eluting stents in saphenous vein graft interventions: a systematic review. EuroIntervention 5, 722–730 (2010).
   PubMed Web of Science ®Google Scholar
• Genereux P, Palmerini T, Caixeta A et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J. Am. Coll. Cardiol. 59, 2165–2174 (2012).
   PubMed Web of Science ®Google Scholar
• Garcia S, Sandoval Y, Roukoz H et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J. Am. Coll. Cardiol. doi:10.1016/j.jacc.2013.05.033 (2013) ( Epub ahead of print).
   Google Scholar
• Colmenarez HJ, Escaned J, Fernandez C et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 55, 1854–1866 (2010).
   PubMed Web of Science ®Google Scholar
• Niccoli G, Leo A, Giubilato S et al. A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome. Int. J. Cardiol. 150, 351–354. (2011)
   PubMed Web of Science ®Google Scholar
• Ma J, Yang W, Singh M, Peng T, Fang N, Wei M. Meta-analysis of long-term outcomes of drug-eluting stent implantations for chronic total coronary occlusions. Heart Lung 40, e32–40 (2011).
   Google Scholar
• Huang PH, Yeung M, Lasala JM et al. Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE program. J. Interv. Cardiol. 24, 232–240 (2011).
   PubMed Web of Science ®Google Scholar
• Kato M, Kimura T, Morimoto T et al. Comparison of five-year outcome of sirolimus-eluting stent implantation for chronic total occlusions versus for non-chronic total occlusion (from the j-Cypher registry). Am. J. Cardiol. 110, 1282–1289 (2012).
   PubMed Web of Science ®Google Scholar
• Mehran R, Claessen BE, Godino C et al. Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc. Interv. 4, 952–961 (2011).
   PubMed Web of Science ®Google Scholar
• De Felice F, Fiorilli R, Parma A et al. Five-year outcomes in patients with chronic total coronary occlusion treated with drug-eluting vs bare-metal stents: a case-control study. Can. J. Cardiol. 29(8), 945–950 (2012).
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Rao SV, Moses JW et al. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting S tents/Total Occlusion Study of Coronary Arteries-4) trial. JACC Cardiovasc. Interv. 2, 97–106 (2009).
   PubMed Web of Science ®Google Scholar
• Galassi AR, Tomasello SD, Costanzo L, Campisano MB, Barrano G, Tamburino C. Long-term clinical and angiographic results of Sirolimus-Eluting stent in Complex coronary chronic Total Occlusion Revascularization: the SECTOR registry. J. Interv. Cardiol. 24, 426–436 (2011).
   PubMed Web of Science ®Google Scholar
• Patel MR, Marso SP, Dai D et al. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005–2008. JACC Cardiovasc. Interv. 5, 1054–1061 (2012).
   PubMed Web of Science ®Google Scholar
• Kelbaek H, Helqvist S, Thuesen L et al. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial. Am. Heart J. 152, 882–886 (2006).
   PubMed Web of Science ®Google Scholar
• Kelbaek H, Klovgaard L, Helqvist S et al. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. J. Am. Coll. Cardiol. 51, 2011–2016 (2008).
   PubMed Web of Science ®Google Scholar
• Suttorp MJ, Laarman GJ, Rahel BM et al. Primary stenting of totally occluded native coronary arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 114, 921–928 (2006).
   PubMed Web of Science ®Google Scholar
• Van den Branden BJ, Rahel BM, Laarman GJ et al. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). EuroIntervention 7, 1189–1196 (2012).
   PubMed Web of Science ®Google Scholar
• Rubartelli P, Petronio AS, Guiducci V et al. Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial. Eur. Heart J. 31, 2014–2020 (2010).
   PubMed Web of Science ®Google Scholar
• Reifart N, Hauptmann KE, Rabe A, Enayat D, Giokoglu K. Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial. EuroIntervention 6, 356–360 (2010).
   PubMed Web of Science ®Google Scholar
• Palmerini T, Biondi-Zoccai G, Della Riva D et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379, 1393–1402 (2012).
   PubMed Web of Science ®Google Scholar
• Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N. Engl. J. Med. 368, 254–265 (2013).
   PubMed Web of Science ®Google Scholar
• Valenti R, Vergara R, Migliorini A et al. Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion. J. Am. Coll. Cardiol. 61, 545–550 (2013).
   PubMed Web of Science ®Google Scholar
• Wohrle J, Rottbauer W, Imhof A. Everolimus-eluting stents for treatment of chronic total coronary occlusions. Clin. Res. Cardiol. 101, 23–28 (2012).
   PubMed Web of Science ®Google Scholar
• Valenti R, Vergara R, Migliorini A et al. Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions. Am. J. Cardiol. 107, 1768–1771 (2011).
   PubMed Web of Science ®Google Scholar
• Almalla M, Hennings V, Marx N, Hoffmann R. Long-term clinical and angiographic outcome after treatment of chronic total occlusion with everolimus or sirolimus eluting stents. Int. J. Cardiol. 157, 451–452 (2012).
   PubMed Web of Science ®Google Scholar
• Moreno R, Garcia E, Teles R et al. Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circ. Cardiovasc. Interv. 6, 21–28 (2013).
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim HY, Lee JM et al. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial. Circ. J. 76, 868–875 (2012).
   PubMed Web of Science ®Google Scholar
• Suttorp MJ, Laarman GJ. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study. Am. Heart J. 154, 432–435 (2007).
   PubMed Web of Science ®Google Scholar
• Wohrle J, Werner GS. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries. Catheter. Cardiovasc. Interv. 81, 793–799 (2013).
   PubMed Web of Science ®Google Scholar
• Garcia S, Brilakis ES. Optimal stenting strategy for coronary chronic total occlusion interventions: what is next? Catheter. Cardiovasc. Interv. 81, 800–801 (2013).
   PubMed Web of Science ®Google Scholar
• Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions. Circ. Cardiovasc. Interv. 5, 729–738 (2012).
   PubMed Web of Science ®Google Scholar
• Colombo A, Mikhail GW, Michev I et al. Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique. Catheter. Cardiovasc. Interv. 64, 407–411, discussion 12 (2005).
   PubMed Web of Science ®Google Scholar
• Godino C, Latib A, Economou FI et al. Coronary chronic total occlusions: mid-term comparison of clinical outcome following the use of the guided-STAR technique and conventional anterograde approaches. Catheter. Cardiovasc. Interv. 79, 20–27 (2012).
   PubMed Web of Science ®Google Scholar
• Brilakis ES, Grantham JA, Rinfret S et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc. Interv. 5, 367–379 (2012).
   PubMed Web of Science ®Google Scholar
• Galassi AR, Tomasello SD, Costanzo L et al. Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion. Catheter. Cardiovasc. Interv. 79, 30–40 (2012).
   PubMed Web of Science ®Google Scholar
• Lombardi WL. Retrograde PCI: what will they think of next? J. Invasive Cardiol. 21, 543 (2009).
   PubMed Web of Science ®Google Scholar
• Brilakis ES, Grantham JA, Thompson CA et al. The retrograde approach to coronary artery chronic total occlusions: a practical approach. Catheter. Cardiovasc. Interv. 79, 3–19 (2012).
   PubMed Web of Science ®Google Scholar
• Karmpaliotis D, Michael TT, Brilakis ES et al. Retrograde coronary chronic total occlusion revascularizationprocedural and in-hospital outcomes from a multicenter registry in the United States. JACC Cardiovasc. Interv. 5, 1273–1279 (2012).
   PubMed Web of Science ®Google Scholar
• Whitlow PL, Burke MN, Lombardi WL et al. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial. JACC Cardiovasc. Interv. 5, 393–401 (2012).
   PubMed Web of Science ®Google Scholar
• Lee NH, Seo HS, Choi JH, Suh J, Cho YH. Recanalization strategy of retrograde angioplasty in patients with coronary chronic total occlusion -analysis of 24 cases, focusing on technical aspects and complications. Int. J. Cardiol. 144, 219–229 (2010).
   PubMed Web of Science ®Google Scholar
• Mogabgab O, Patel VG, Michael TT et al. Long-term outcomes with use of the Bridgepoint Medical System for the recanalization of coronary chronic total occlusions. J. Invasive Cardiol. (2013) ( In Press).
   Google Scholar
• Park JJ, Chae IH, Cho YS et al. The recanalization of chronic total occlusion leads to lumen area increase in distal reference segments in selected patients: an intravascular ultrasound study. JACC Cardiovasc. Interv. 5, 827–836 (2012).
   PubMedGoogle Scholar
• Galassi AR, Tomasello SD, Crea F et al. Transient impairment of vasomotion function after successful chronic total occlusion recanalization. J. Am. Coll. Cardiol. 59, 711–718 (2012).
   PubMed Web of Science ®Google Scholar
• Lee SP, Shin DH, Park KW et al. Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents. Int. J. Cardiol. 156, 180–185 (2012).
   PubMed Web of Science ®Google Scholar
• Liu W, Wagatsuma K, Nii H, Toda M, Amano H, Uchida Y. Impact of diabetes on long term follow-up of elderly patients with chronic total occlusion post percutaneous coronary intervention. J. geriatr. Cardiol. 10, 16–20 (2013).
   PubMedGoogle Scholar
• Al-Lamee R, Ielasi A, Latib A et al. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Am. J. Cardiol. 106, 1721–1727 (2010).
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J. Am. Coll. Cardiol. 58, e44–122 (2011).
   PubMed Web of Science ®Google Scholar
• Brilakis ES, Banerjee S. Advances in the treatment of coronary artery aneurysms. Catheter. Cardiovasc. Interv. 77, 1042–1044 (2011).
   PubMed Web of Science ®Google Scholar
• Teeuwen K, Adriaenssens T, Van den Branden BJ et al. A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study. Trials 13, 240 (2012).
   PubMed Web of Science ®Google Scholar